Llwytho...
Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer’s Disease
The NIA-AA criteria for “preclinical” Alzheimer’s disease (AD) propose a staging method in which AD biomarkers follow an invariable temporal sequence in accordance with the amyloid cascade hypothesis. However, recent findings do not align with the proposed temporal sequence and “subtle cognitive dec...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Alzheimers Dis |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4634634/ https://ncbi.nlm.nih.gov/pubmed/26402771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-150128 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|